Robot-assisted Extraperitoneal Para-aortic Lymphadenectomy Is Associated with Fewer Surgical Complications: A Post Hoc Analysis of the STELLA-2 Randomized Trial.

Journal: Journal of minimally invasive gynecology
Published Date: May 20, 2021

Abstract

STUDY OBJECTIVE: To evaluate if extraperitoneal para-aortic lymphadenectomy (PALND) using a robot-assisted approach was associated with fewer complications than all other approaches (conventional laparoscopic transperitoneal or extraperitoneal and robot-assisted transperitoneal) without compromising lymph node yield, operative time, or length of stay.

Authors

  • Vicente Bebia
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo).
  • Antonio Gil-Moreno
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo); Universitat Autònoma de Barcelona (Drs. Gil-Moreno, Cabrera, and Pérez-Benavente); Centro de Investigación Biomédica en Red de Cáncer (Drs. Gil-Moreno and de la Torre). Electronic address: antonioimma@yahoo.es.
  • Alicia Hernández
    Department of Gynecology, Hospital Universitario La Paz (Drs. Hernández, Siegrist, and Chipirliu), Madrid.
  • Juan Gilabert-Estellés
    Department of Gynecology, Hospital General Universitario de Valencia, Valencia (Drs. Gilabert-Estellés and Díaz-Feijoo), Spain.
  • Silvia Franco-Camps
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo).
  • Javier de la Torre
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo).
  • Jaime Siegrist
    Department of Gynecology, Hospital Universitario La Paz (Drs. Hernández, Siegrist, and Chipirliu), Madrid.
  • Anca Chipirliu
    Department of Gynecology, Hospital Universitario La Paz (Drs. Hernández, Siegrist, and Chipirliu), Madrid.
  • Silvia Cabrera
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo); Universitat Autònoma de Barcelona (Drs. Gil-Moreno, Cabrera, and Pérez-Benavente).
  • Melissa Bradbury
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo).
  • Assumpció Pérez-Benavente
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo); Universitat Autònoma de Barcelona (Drs. Gil-Moreno, Cabrera, and Pérez-Benavente).
  • Berta Díaz-Feijoo
    Gynecological Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (Drs. Bebia, Gil-Moreno, Franco-Camps, de la Torre, Cabrera, Bradbury, Pérez-Benavente, and Díaz-Feijoo); Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona (Dr. Díaz-Feijoo); Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona (Dr. Díaz-Feijoo), Barcelona; Department of Gynecology, Hospital General Universitario de Valencia, Valencia (Drs. Gilabert-Estellés and Díaz-Feijoo), Spain.

Keywords

External Resources

Popular Topics
Recent Journals